Kathmandu
Cancer Center
Kathmandu
Cancer Center
If you have started chemotherapy, immunotherapy or targeted therapy at Rajiv Gandhi, Tata Memorial, Apollo or Medanta — you can continue the same treatment at Kathmandu Cancer Center without interruption, without restarting, and without going back to India for every cycle.
You made the decision to go to India because you wanted the best for someone you love. That decision cost more than you expected — in money, in time, in separation from family. The flights. The accommodation in Delhi or Chennai. Weeks away from home. The paperwork. The language barrier at the clinic. The exhaustion of doing all of this while also being afraid.
And now you are asking a question you may be afraid to ask out loud: if I come back to Nepal, will my treatment stop? Will I lose the cycles I've already been through? Will the drugs be available? Will the doctors understand my case?
These are not small questions. They deserve direct, clinical answers — not general reassurance. This page gives you those answers specifically, drug by drug, step by step. And if something in your case is not available at KCC, we will tell you that too. That is a commitment.
A treatment transfer is not starting over. These three clinical facts apply to every patient who transfers care to KCC from an Indian hospital.
KCC follows the same NCCN, ESMO and WHO treatment guidelines as RGCI, Tata Memorial, Apollo and Medanta. The regimen your Indian oncologist prescribed does not change. We continue it — we do not redesign it.
Same protocolEvery cycle you have completed in India is fully documented and counted. KCC continues from your next scheduled dose. There is no restart, no repeat of doses you have already received, no lost progress.
No restartBefore you make any decision, before you travel to Kathmandu, KCC confirms that your specific drugs are available at the required dose. We do not ask you to come and then tell you. We confirm first.
Confirmed before you travelThe following standard protocols and drugs are available at KCC Nepal. This is not an exhaustive formulary — it is the most common treatments Nepali patients return from India carrying. Send us your specific protocol and we will confirm within 24 hours.
No ambiguity. No "we'll figure it out when you arrive." Here is the exact process, step by step, with realistic timelines.
WhatsApp or email your treatment summary, drug protocol, pathology, staging scans, and recent blood work to KCC. No referral letter required.
Day 1The relevant KCC specialist reviews your complete case. Your treatment plan is assessed by the tumour board if complex. You receive a clear written response.
24–48 hoursKCC pharmacy confirms your specific drugs, doses, and brands are available before you travel. If anything needs to be sourced, we tell you the timeline.
48–72 hoursYou attend KCC for a clinical review with the specialist, pre-treatment bloods, and your first continued-cycle appointment. Treatment resumes.
3–5 working daysThe more complete the documents you share, the faster we can confirm and schedule. Photos of printed documents on WhatsApp are fine — perfection is not required.
WhatsApp photos of printed documents are completely acceptable. PDFs by email also work. We do not need originals. You will receive a response from a clinical team member — not a call centre.
WhatsApp Documents Now — 9818-226237 Email: [email protected]Response within 24–48 hours from a clinical team member. If your case is urgent, call 01-5091629 directly.
Accommodation near KCC Bhaktapur (Tathali): Affordable rooms and small apartments are available in the local area near the Tathali campus — within 5–10 minutes of the hospital. Our front desk team will help you identify suitable options based on your budget and length of stay when you contact us. There is no need to arrange this before you arrive — just ask when you call or WhatsApp.
Real families. Real treatment transfers. The fear of interruption was real — and it did not happen.
I was on FOLFOX for rectal cancer — cycle 4 of 8 — when we ran out of money to stay in Delhi. I thought I would have to stop treatment completely. I contacted KCC and sent my protocol by WhatsApp. They confirmed all three drugs within one day. I started cycle 5 at KCC the following week. Not a single cycle was lost.
My mother was receiving Trastuzumab for HER2+ breast cancer at Apollo. After three cycles we could no longer manage the cost and the travel. My biggest fear was that she would lose the benefit of the cycles she had already received. KCC told us clearly: the cycles are preserved, we continue from cycle four. She completed the full course. She is doing well.
We were told Pembrolizumab was only available in India. When I contacted KCC I was surprised — they confirmed it was available here, for the same indication, within 24 hours. I wish I had asked before making two trips to Delhi. The treatment is the same. The cost is significantly less. My family has been with me at every session.
Send us your treatment summary. Our clinical team will review it, confirm drug availability, and tell you exactly what transferring to KCC would mean for your specific case — including if we believe continuing in India is the right decision. That is a promise.
We confirm before you travel. And if India is the right answer, we will say so.